查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
醫療對策市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2023年～2030年)- 各產品，各用途，各地區(北美，歐洲，亞太地區，南美，中東·非洲)
市場調查報告書
商品編碼
1312416

醫療對策市場 - 全球產業分析，規模，佔有率，成長，趨勢，預測(2023年～2030年)- 各產品，各用途，各地區(北美，歐洲，亞太地區，南美，中東·非洲)

Medical Countermeasures Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 220 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

由於對經濟實惠且有效的藥物的需求不斷增長，以應對不確定的疫情，全球醫療響應市場的規模正在醫療保健行業實現飛躍。由於需要強有力且有針對性的醫療干預措施來維持醫護人員的努力並防止疾病傳播，藥物安全保障市場正在朝著顯著增長的方向發展。

本報告提供全球醫療對策市場相關調查，提供市場概要，以及各類型，各產品，各用途，向各地區趨勢，及市場參與市場企業的競爭趨勢等資訊。

目錄

第1章 摘要整理

第2章 市場概要

  • 市場定義和市場區隔
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 法律規範
  • 政府的配合措施投資
  • 技術的進步
  • 大環境分析
  • 價值鏈分析
  • COVID-19影響分析

第3章 全球醫療對策市場預測，2018年～2030年

  • 全球醫療對策市場預測，各類型，2018年～2030年
  • 全球醫療對策市場預測，各產品，2018年～2030年
  • 全球醫療對策市場預測，各用途，2018年～2030年
  • 全球醫療對策市場預測，各地區，2018年～2030年

第4章 北美的醫療對策市場預測，2018年～2030年

第5章 歐洲的醫療對策市場預測，2018年～2030年

第6章 亞太地區的醫療對策市場預測，2018年～2030年

第7章 南美的醫療對策市場預測，2018年～2030年

第8章 中東·非洲的醫療對策市場預測，2018年～2030年

第9章 競爭情形

  • 市場佔有率分析
  • 企業簡介
    • Pfizer, Inc.
    • Altimmune, Inc.
    • SIGA Technologies
    • Bavarian Nordic A/S
    • Dynavax Technologies Corporation
    • National Resilience, Inc.
    • GSK plc
    • Xoma Corporation
    • Meridian Medical Technologies, LLC
    • Bruker Detection
    • Ichor Medical Systems
    • Teledyne Technologies, Inc.
    • 其他

第10章 附錄

簡介目錄

The global medical countermeasures market is experiencing a major breakthrough in the healthcare industry, driven by the increasing demand for accessible and effective medicines to combat uncertain outbreaks. With the need for robust and apt medical countermeasures to sustain the efforts of healthcare workers and prevent the spread of diseases, the market is advancing towards significant growth in the safety assurance of drugs.

Growing Demand for Medical Countermeasures in the Face of Uncertain Outbreaks

Healthcare providers are increasingly relying on medical countermeasures to address the uncertainty of outbreaks and ensure accessible medicines with fewer side effects upon successful diagnosis. The availability of extensive vaccines or antivirals that are unapproved can lead to ineffective treatments, undermining efforts to produce safe and effective drugs. To maintain consistent efforts in healthcare and prevent diseases from spreading, the demand for robust and suitable medical countermeasures has risen incessantly.

Rigorous Quality Checks and Clinical Trials Enhance Market Potential

Before entering the market, drugs undergo rigorous quality checks and clinical trials to ensure their safety and efficacy. Government agencies like the U.S. Food and Drug Administration (FDA) pre-evaluate medications sold in the market, further assuring safety to consumers. These stringent quality checks, coupled with growing awareness of medical countermeasures and unpredictable outbreaks, are expected to expand the dimensions of the medical countermeasures market and boost sales in the coming years.

Rising Prevalence of Infectious Diseases and Advancements in Precision Medicines Propel Market Growth

The medical countermeasures market, comprising medical devices and therapeutic products, is dominated by vaccines, particularly due to the prevalence of infectious diseases like HIV/AIDS. The market is witnessing continuous growth as an increasing number of patients require life-saving vaccines to combat lethal diseases such as dengue and influenza virus (H1N1). Advancements in personalized medicine and Matrix Metalloproteinases (MMPs) are also expected to drive market expansion. Additionally, rising awareness about countermeasures to combat biological agents further boosts the momentum for the medical countermeasures market.

Asia Pacific Emerges as a Promising Market with Robust Investments in Research & Development

While the U.S. leads the global medical countermeasures market with strict norms and regulations on drug development and rising awareness about bioterrorism attacks, Asia Pacific is poised to demonstrate substantial growth during the forecast period. The region's market is influenced by increasing biological warfare threats and growing investments in research and development by key players to develop countermeasures against bio aggressors. Moreover, the region's sophisticated infrastructure and government investments in the latest countermeasures and R&D contribute to market growth.

Leading Players Shaping the Global Medical Countermeasures Market

Some of the prominent players operating in the global medical countermeasures market include: Sanofi Pasteur, Johnson & Johnson, CSL Limited, GlaxoSmithKline plc, Pfizer, Inc., Emergent BioSolutions, Inc., Daiichi Sankyo Company, Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Bavarian Nordic, AstraZeneca, Bharat Biotech, Incepta Vaccine Ltd., Biological E, Sinovac Biotech Ltd., Valneva SE, PT Bio Farma, Panacea Biotec, and VBI Vaccines Inc.

Table of Contents

1. Executive Summary

  • 1.1. Global Medical Countermeasures Market Outlook, 2018 - 2030 (US$ Million)
  • 1.2. Global Medical Countermeasures Market Incremental Opportunity, 2018 - 2030 (US$ Million)
  • 1.3. Key Industry Trends

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
      • 2.2.1.1. Driver 1
      • 2.2.1.2. Driver 2
    • 2.2.2. Restraints
      • 2.2.2.1. Restraint 1
      • 2.2.2.2. Restraint 2
    • 2.2.3. Opportunities
      • 2.2.3.1. Opportunity 1
      • 2.2.3.2. Opportunity 2
  • 2.3. Regulatory Framework
  • 2.4. Government Initiatives and Investments
  • 2.5. Technological Advancements
  • 2.6. PESTLE Analysis
  • 2.7. Value Chain Analysis
  • 2.8. COVID-19 Impact Analysis

3. Global Medical Countermeasures Market Outlook, 2018 - 2030

  • 3.1. Global Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 3.1.1. Key Highlights
    • 3.1.2. Global Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 3.1.2.1. Drugs
      • 3.1.2.2. Biologics
      • 3.1.2.3. Devices
    • 3.1.3. Global Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
    • 3.1.4. Global Medical Countermeasures Market Attractiveness Analysis, by Type, 2023 - 2030
  • 3.2. Global Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 3.2.1. Key Highlights
    • 3.2.2. Global Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 3.2.2.1. Diagnostic
      • 3.2.2.2. Therapeutic
      • 3.2.2.3. Prophylactic
    • 3.2.3. Global Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
    • 3.2.4. Global Medical Countermeasures Market Attractiveness Analysis, By Product, 2023 - 2030
  • 3.3. Global Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 3.3.1. Key Highlights
    • 3.3.2. Global Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 3.3.2.1. Small pox
      • 3.3.2.2. Anthrax
      • 3.3.2.3. Botulism
      • 3.3.2.4. Chemical Threat
      • 3.3.2.5. Radiological/Nuclear Threat
      • 3.3.2.6. Emerging Infectious Diseases
      • 3.3.2.7. Others
    • 3.3.3. Global Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
    • 3.3.4. Global Medical Countermeasures Market Attractiveness Analysis, by Application, 2023 - 2030
  • 3.4. Global Medical Countermeasures Market Outlook, By Region, 2018 - 2030
    • 3.4.1. Key Highlights
    • 3.4.2. Global Medical Countermeasures Market Outlook, by Region, Value (US$ Million), 2018 - 2030
      • 3.4.2.1. North America
      • 3.4.2.2. Europe
      • 3.4.2.3. Asia Pacific
      • 3.4.2.4. Latin America
      • 3.4.2.5. Middle East & Africa
    • 3.4.3. Global Medical Countermeasures Market Share and BPS Analysis, by Region, 2023 and 2030
    • 3.4.4. Global Medical Countermeasures Market Attractiveness Analysis, by Region, 2023 - 2030

4. North America Medical Countermeasures Market Outlook, 2018 - 2030

  • 4.1. North America Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 4.1.1. Key Highlights
    • 4.1.2. North America Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 4.1.2.1. Drugs
      • 4.1.2.2. Biologics
      • 4.1.2.3. Devices
    • 4.1.3. North America Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 4.2. North America Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 4.2.1. Key Highlights
    • 4.2.2. North America Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 4.2.2.1. Diagnostic
      • 4.2.2.2. Therapeutic
      • 4.2.2.3. Prophylactic
    • 4.2.3. North America Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 4.3. North America Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 4.3.1. Key Highlights
    • 4.3.2. North America Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 4.3.2.1. Small pox
      • 4.3.2.2. Anthrax
      • 4.3.2.3. Botulism
      • 4.3.2.4. Chemical Threat
      • 4.3.2.5. Radiological/ Nuclear Threat
      • 4.3.2.6. Emerging Infectious Diseases
      • 4.3.2.7. Others
    • 4.3.3. North America Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 4.4. North America Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 4.4.1. Key Highlights
    • 4.4.2. North America Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 4.4.2.1. U.S.
      • 4.4.2.2. Canada
    • 4.4.3. North America Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

5. Europe Medical Countermeasures Market Outlook, 2018 - 2030

  • 5.1. Europe Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 5.1.1. Key Highlights
    • 5.1.2. Europe Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 5.1.2.1. Drugs
      • 5.1.2.2. Biologics
      • 5.1.2.3. Devices
    • 5.1.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 5.2. Europe Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 5.2.1. Key Highlights
    • 5.2.2. Europe Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 5.2.2.1. Diagnostic
      • 5.2.2.2. Therapeutic
      • 5.2.2.3. Prophylactic
    • 5.3.3. Europe Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 5.3. Europe Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 5.3.1. Key Highlights
    • 5.3.2. Europe Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 5.3.2.1. Small pox
      • 5.3.2.2. Anthrax
      • 5.3.2.3. Botulism
      • 5.3.2.4. Chemical Threat
      • 5.3.2.5. Radiological/Nuclear Threat
      • 5.3.2.6. Emerging Infectious Diseases
      • 5.3.2.7. Others
    • 5.3.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 5.4. Europe Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 5.4.1. Key Highlights
    • 5.4.2. Europe Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 5.4.2.1. Germany
      • 5.4.2.2. France
      • 5.4.2.3. U.K.
      • 5.4.2.4. Italy
      • 5.4.2.5. Spain
      • 5.4.2.6. Russia
      • 5.4.2.7. Rest of Europe
    • 5.4.3. Europe Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

6. Asia Pacific Medical Countermeasures Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 6.1.1. Key Highlights
    • 6.1.2. Asia Pacific Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 6.1.2.1. Drugs
      • 6.1.2.2. Biologics
      • 6.1.2.3. Devices
    • 6.1.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 6.2. Asia Pacific Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 6.2.1. Key Highlights
    • 6.2.2. Asia Pacific Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 6.2.2.1. Diagnostic
      • 6.2.2.2. Therapeutic
      • 6.2.2.3. Prophylactic
    • 6.2.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 6.3. Asia Pacific Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 6.3.1. Key Highlights
    • 6.3.2. Asia Pacific Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 6.3.2.1. Small pox
      • 6.3.2.2. Anthrax
      • 6.3.2.3. Botulism
      • 6.3.2.4. Chemical Threat
      • 6.3.2.5. Radiological/Nuclear Threat
      • 6.3.2.6. Emerging Infectious Diseases
      • 6.3.2.7. Others
    • 6.3.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 6.4. Asia Pacific Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 6.4.1. Key Highlights
    • 6.4.2. Asia Pacific Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 6.4.2.1. Japan
      • 6.4.2.2. China
      • 6.4.2.3. India
      • 6.4.2.4. Australia & New Zealand
      • 6.4.2.5. South Korea
      • 6.4.2.6. Rest of Asia Pacific
    • 6.4.3. Asia Pacific Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

7. Latin America Medical Countermeasures Market Outlook, 2018 - 2030

  • 7.1. Latin America Medical Countermeasures Market Outlook, by Type, 2018 - 2030
    • 7.1.1. Key Highlights
    • 7.1.2. Latin America Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 7.1.2.1. Drugs
      • 7.1.2.2. Biologics
      • 7.1.2.3. Devices
    • 7.1.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 7.2. Latin America Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 7.2.1. Key Highlights
    • 7.2.2. Latin America Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 7.2.2.1. Diagnostic
      • 7.2.2.2. Therapeutic
      • 7.2.2.3. Prophylactic
    • 7.2.3. Latin America Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 7.3. Latin America Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 7.3.1. Key Highlights
    • 7.3.2. Latin America Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 7.3.2.1. Small pox
      • 7.3.2.2. Anthrax
      • 7.3.2.3. Botulism
      • 7.3.2.4. Chemical Threat
      • 7.3.2.5. Radiological/Nuclear Threat
      • 7.3.2.6. Emerging Infectious Diseases
      • 7.3.2.7. Others
    • 7.3.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 7.4. Latin America Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 7.4.1. Key Highlights
    • 7.4.2. Latin America Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 7.4.2.1. Brazil
      • 7.4.2.2. Mexico
      • 7.4.2.3. Argentina
      • 7.4.2.4. Rest of Latin America
    • 7.4.3. Latin America Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

8. Middle East & Africa Medical Countermeasures Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Medical Countermeasures Market Outlook, Type, 2018 - 2030
    • 8.1.1. Key Highlights
    • 8.1.2. Middle East & Africa Medical Countermeasures Market Outlook, by Type, Value (US$ Million), 2018 - 2030
      • 8.1.2.1. Drugs
      • 8.1.2.2. Biologics
      • 8.1.2.3. Devices
    • 8.1.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Type, 2023 and 2030
  • 8.2. Middle East & Africa Medical Countermeasures Market Outlook, By Product, 2018 - 2030
    • 8.2.1. Key Highlights
    • 8.2.2. Middle East & Africa Medical Countermeasures Market Outlook, By Product, Value (US$ Million), 2018 - 2030
      • 8.2.2.1. Diagnostic
      • 8.2.2.2. Therapeutic
      • 8.2.2.3. Prophylactic
    • 8.2.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, By Product, 2023 and 2030
  • 8.3. Middle East & Africa Medical Countermeasures Market Outlook, By Application, 2018 - 2030
    • 8.3.1. Key Highlights
    • 8.3.2. Middle East & Africa Medical Countermeasures Market Outlook, by Application, Value (US$ Million), 2018 - 2030
      • 8.3.2.1. Small pox
      • 8.3.2.2. Anthrax
      • 8.3.2.3. Botulism
      • 8.3.2.4. Chemical Threat
      • 8.3.2.5. Radiological/Nuclear Threat
      • 8.3.2.6. Emerging Infectious Diseases
      • 8.3.2.7. Others
    • 8.3.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Application, 2023 and 2030
  • 8.4. Middle East & Africa Medical Countermeasures Market Outlook, By Country, 2018 - 2030
    • 8.4.1. Key Highlights
    • 8.4.2. Middle East & Africa Medical Countermeasures Market Outlook, by Country, Value (US$ Million), 2018 - 2030
      • 8.4.2.1. Saudi Arabia
      • 8.4.2.2. UAE
      • 8.4.2.3. South Africa
      • 8.4.2.4. Rest of Middle East & Africa
    • 8.4.3. Middle East & Africa Medical Countermeasures Market Share and BPS Analysis, by Country, 2023 and 2030

9. Competitive Landscape

  • 9.1. Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1. Pfizer, Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product Portfolio
      • 9.2.1.4. Recent Developments
    • 9.2.2. Altimmune, Inc.
    • 9.2.3. SIGA Technologies
    • 9.2.4. Bavarian Nordic A/S
    • 9.2.5. Dynavax Technologies Corporation
    • 9.2.6. National Resilience, Inc.
    • 9.2.7. GSK plc
    • 9.2.8. Xoma Corporation
    • 9.2.9. Meridian Medical Technologies, LLC
    • 9.2.10. Bruker Detection
    • 9.2.11. Ichor Medical Systems
    • 9.2.12. Teledyne Technologies, Inc.
    • 9.2.13. Others

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Specific Research Approach
  • 10.3. Acronyms and Abbreviations